Abstract
Background/Aims: Previous partial hepatectomy (HPTX) can attenuate glycerol-induced acute kidney injury (Gly-AKI). The aim of this study was to explore the pathophysiological mechanisms and the role of hepatocyte growth factor (HGF) in kidney protection. Methods: Rats were subjected to HPTX 24 h before glycerol administration. Renal function, acute tubular necrosis, apoptosis, leukocyte infiltration, and the expression of HGF, c-met, monocyte chemoattractant protein-1, interleukin-1β, and heme oxygenase-1 were evaluated 24 h after glycerol injection. The regenerative response was analyzed from 6 to 72 h after glycerol injection (BrdU incorporation). In a separate series of experiments, Gly-AKI+HPTX rats were treated with anti-HGF antibody. Results: Gly-AKI+HPTX rats showed an increased expression of renal HGF and c-met as well as an improved creatinine clearance and reduced acute tubular necrosis and apoptosis, cytokine expression, and leukocyte infiltration. The regenerative response was less intense 24 and 72 h after glycerol administration in this group. The anti-HGF treatment disclosed an important role of HGF in the reduction of tubular injury, particularly apoptosis. Overexpression of heme oxygenase-1 was observed in Gly-AKI+HPTX rats, but was not associated with HPTX-induced renal protection. Conclusion: We conclude that Gly-AKI+HPTX rats have a reduced susceptibility to renal injury instead of an increased regenerative response and that endogenous HGF overexpression is responsible for suppression of tubular apoptosis.
Journal Section:
Original Paper
References
1.
Wolfert AI, Oken DE: Glomerular hemodynamics in established glycerol-induced acute renal failure in the rat. J Clin Invest 1989;84:1967–1973.
[PubMed]
2.
Homsi E, Janino P, de Faria JB: Role of caspases on cell death, inflammation, and cell cycle in glycerol-induced acute renal failure. Kidney Int 2006;69:1385–1392.
[PubMed]
3.
Hsu CH, Kurtz TW, Waldinger TP: Cardiac output and renal blood flow in glycerol-induced acute renal failure. Circ Res 1977;40:178–182.
[PubMed]
4.
Zager RA: Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int1996;49:314–326.
[PubMed]
5.
Zager RA, Burkhart KM, Conrad DS, Gmur DJ: Iron, heme oxygenase, and glutathione: effects on myohemoglobinuric proximal tubular injury. Kidney Int 1995;48:1624–1634.
[PubMed]
6.
Zager RA, Burkhart KM: Differential effects of glutathione and cysteine on Fe2+, Fe3+, H2O2 and myoglobin-induced proximal tubular cell attack. Kidney Int 1998;53:1661–1672.
[PubMed]
7.
Moore KP, Holt SG, Patel RP, Svitunensko DA, Zackert W, Goodier D, Reeder BJ, Clozel M, Anand R, Cooper CE, Morrow JD, Wilson MT, Darley-Usmar V, Roberts LJ: A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem 1998;273:31731–31737.
[PubMed]
8.
Nakamura T, Nawa K, Ichihara A: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984;122:1450–1459.
[PubMed]
9.
Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S: Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342:440–443.
[PubMed]
10.
Kawaida K, Matsumoto K, Shimazu H, Nakamura T: Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 1994;91:4357–4361.
[PubMed]
11.
Igawa T, Matsumoto K, Kanda S, Saito Y, Nakamura T: Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 1993;265(1 Pt 2):F61–F69.
[PubMed]
12.
Matsumoto K, Nakamura T: Hepatocyte growth factor as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 1997;239:639–644.
[PubMed]
13.
Igawa T, Kanda S, Kanetake H, Saito Y, Ichihara H, Tomita Y, Nakamura T: Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells. Biochem Biophys Res Commun 1991;174:831–838.
[PubMed]
14.
Cantley LG, Barros EJ, Gandhi M, Rauchman M, Nigam SK: Regulation of mitogenesis, motogenesis, and tubulogenesis by hepatocyte growth factor in renal collecting duct cells. Am J Physiol 1994;267(2 Pt 2):F271–F280.
[PubMed]
15.
Liu Y, Sun AM, Dworkin LD: Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death. Biochem Biophys Res Commun 1998;246:821–826.
[PubMed]
16.
Yo Y, Morishita R, Nakamura S, Tomita N, Yamamoto K, Moriguchi A, Matsumoto K, Nakamura T, Higaki J, Ogihara T: Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells. Kidney Int 1998;54:1128–1138.
[PubMed]
17.
Goto T, Sugimura K, Harimoto K, Kasai S, Kim T, Kishimoto T: Hepatocyte growth factor in glycerol-induced acute renal failure. Nephron 1997;77:440–444.
[PubMed]
18.
Nagano T, Mori-Kudo I, Tsuchida A, Kawamura T, Taiji M, Noguchi H: Ameliorative effect of hepatocyte growth factor on glycerol-induced acute renal failure with acute tubular necrosis. Nephron 2002;91:730–738.
[PubMed]
19.
Homsi E, Ribeiro-Alves MA, Lopes de Faria JB, Dias EP: Interleukin-6 stimulates tubular regeneration in rats with glycerol-induced acute renal failure. Nephron 2002;92:192–199.
[PubMed]
20.
Nagano T, Mori-Kudo I, Kawamura T, Taiji M, Noguchi H: Pre- or post-treatment with hepatocyte growth factor prevents glycerol-induce acute renal failure. Ren Fail 2004;26:5–11.
[PubMed]
21.
Kinoshita T, Hirao S, Matsumoto K, Nakamura T: Possible endocrine control by hepatocyte growth factor of liver regeneration after partial hepatectomy. Biochem Biophys Res Commun 1991;177:330–335.
[PubMed]
22.
Kono S, Nagaike M, Matsumoto K, Nakamura T: Marked induction of hepatocyte growth factor mRNA in intact kidney and spleen in response to injury in distant organs. Biochem Biophys Res Commun 1992;186:991–998.
[PubMed]
23.
Homsi E, Pires de Oliveira Dias E, Figueiredo JF, Gontijo JA: Accelerated recovery of glycerol-induced acute renal failure in rats with previous partial hepatectomy. Exp Nephrol 1998;6:551–556.
[PubMed]
24.
Higgins GM, Handerson RM: Restoration of the liver of white rats following surgical partial hepatectomy. Arch Cardiol 1931;12:18.
25.
Ohmichi H, Koshimizu U, Matsumoto K, Nakamura T: Hepatocyte growth factor acts as a mesenchyme-derived morphogenic factor during fetal lung development. Development 1998;125:1315–1324.
[PubMed]
26.
Yamada T, Hisanaga M, Nakajima Y, Mizuno S, Matsumoto K, Nakamura T, Nakano H: Enhanced expression of hepatocyte growth factor by pulmonary ischemia-reperfusion injury in the rat. Am J Respir Crit Care Med 2000;162:707–715.
[PubMed]
27.
Nath KA, Balla G, Vercellotti GM, Balla J, Jacob HS, Levitt MD, Rosenberg ME: Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 1992;90:267–270.
[PubMed]
28.
Matsumoto K, Nakamura T: Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int 2001;59; 2023–2038.
[PubMed]
30.
Mizuno S, Nakamura T: Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys. Am J Pathol 2005;166:1895–1905.
[PubMed]
31.
Fiaschi-Taesch NM, Santos S, Reddy V, Van Why SK, Philbrick WF, Ortega A, Esbrit P, Orloff JJ, Garcia-Ocaña A: Prevention of acute ischemic renal failure by targeted delivery of growth factors to the proximal tubule in transgenic mice: the efficacy of parathyroid hormone-related protein and hepatocyte growth factor. J Am Soc Nephrol 2004;15:112–125.
[PubMed]
32.
Dai C, Yang J, Liu Y: Single injection of naked plasmid encoding hepatocyte growh factor prevents cell death and ameliorates acute renal failure in mice. J Am Soc Nephrol 2002;13:411–422.
[PubMed]
33.
Franquesa M, Alperovich G, Herrero-Fresneda I, Lloberas N, Bolaños N, Fillat C, Rama I, Cruzado JM, Grinyó JM, Torras J: Direct electrotransfer of hHGF gene into kidney ameliorates ischemic acute renal failure. Gene Ther 2005;12:1551–1558.
[PubMed]
34.
Miller SB, Martin DR, Kissane J, Hammerman MR: Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol 1994;266(1 Pt 2):F129–F134.
[PubMed]
35.
de Souza Durão M Jr, Razvickas CV, Gonçalves EA, Okano IR, Camargo SM, Monte JC, dos Santos OF: The role of growth factors on renal tubular cells submitted to hypoxia and deprived of glucose. Ren Fail 2003;25:341–353.
[PubMed]
36.
Liu Y: Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms. Am J Physiol 1999;277(4 Pt 2):F624–F633.
[PubMed]
37.
Romashkova JA, Makarov SS: NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999;401:86–90.
[PubMed]
38.
Kucharczak J, Simmons MJ, Fan Y, Gelinas C: To be, or not to be: NF-kappaB is the answer – role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 2003;22:8961–8982.
[PubMed]
39.
Bonventre JV, Zuk A: Ischemic acute renal failure: an inflammatory disease? Kidney Int 2004;66:480–485.
[PubMed]
40.
Mizuno S, Nakamura T: Suppressions of chronic glomerular injuries and TGF-beta1 production by HGF in attenuation of murine diabetic nephropathy. Am J Physiol Renal Physiol2004;286:F134–F143.
[PubMed]
41.
Gong R, Rifai A, Tolbert EM, Biswas P, Centracchio JN, Dworkin LD: Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES.J Am Soc Nephrol 2004;15:2868–2881.
42.
Gong R, Rifai A, Dworkin LD: Hepatocyte growth factor suppresses acute renal inflammation by inhibition of endothelial E-selectin. Kidney Int 2006;69:1166–1174.
[PubMed]
43.
Gong R, Rifai A, Dworkin LD: Anti-inflammatory effect of hepatocyte growth factor in chronic kidney disease: targeting the inflamed vascular endothelium. J Am Soc Nephrol 2006;17:2464–2473.
[PubMed]
44.
Ryter SW, Alam J, Choi AM: Heme oxigenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006;86:583–650.
[PubMed]
45.
Stocker R: Induction of haem oxygenase as a defence against oxidative stress. Free Radic Res Commun 1990;9:101–112.
[PubMed]
46.
Zhang X, Shan P, Otterbein LE, Alam J, Flavell RA, Davis RJ, Choi AM, Lee PJ: Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase and involves caspase-3. J Biol Chem 2003;278:1248–1258.
[PubMed]
47.
Zhang F, Kaide J, Wei Y, Jiang H, Yu C, Balazy M, Abraham NG, Wang W, Nasjletti A: Carbon monoxide produced by isolated arterioles attenuates pressure-induced vasoconstriction. Am J Physiol Heart Circ Physiol 2001;281:H350–H358.
[PubMed]
48.
Nath KA, Haggard JJ, Croatt AJ, Grande JP, Poss KD, Alam J: The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am J Pathol 2000;156:1527–1535.
[PubMed]
49.
Rampino T, Arbustini E, Gregorini M, Guallini P, Libetta C, Maggio M, Ranghino A, Silini E, Soccio G, Dal Canton A: Hemodialysis prevents liver disease caused by hepatitis C virus: role of hepatocyte growth factor. Kidney Int 1999;56:2286–2291.
[PubMed]
© 2007 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2007
You do not currently have access to this content.
